IRIS
CHISARI, CLARA GRAZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.707
AS - Asia 2.722
EU - Europa 2.631
SA - Sud America 475
AF - Africa 426
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 10.967
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.575
SG - Singapore 1.457
RU - Federazione Russa 1.175
CN - Cina 782
IT - Italia 639
BR - Brasile 421
IE - Irlanda 335
CI - Costa d'Avorio 292
KR - Corea 133
VN - Vietnam 133
UA - Ucraina 116
CA - Canada 96
GB - Regno Unito 69
DE - Germania 67
SN - Senegal 62
IN - India 59
FR - Francia 51
NL - Olanda 37
SE - Svezia 30
PL - Polonia 29
FI - Finlandia 26
TR - Turchia 26
MX - Messico 25
ZA - Sudafrica 24
BJ - Benin 21
AR - Argentina 20
JP - Giappone 20
HK - Hong Kong 16
BD - Bangladesh 15
CH - Svizzera 14
UZ - Uzbekistan 12
ID - Indonesia 11
EC - Ecuador 10
IQ - Iraq 10
PK - Pakistan 10
VE - Venezuela 10
ES - Italia 8
AE - Emirati Arabi Uniti 7
AT - Austria 7
CZ - Repubblica Ceca 6
KE - Kenya 6
NG - Nigeria 6
EG - Egitto 5
IR - Iran 5
PY - Paraguay 5
BG - Bulgaria 4
DO - Repubblica Dominicana 4
GR - Grecia 4
NP - Nepal 4
PE - Perù 4
SA - Arabia Saudita 4
AZ - Azerbaigian 3
JO - Giordania 3
LT - Lituania 3
MA - Marocco 3
TN - Tunisia 3
AU - Australia 2
BE - Belgio 2
CL - Cile 2
CO - Colombia 2
DM - Dominica 2
DZ - Algeria 2
EU - Europa 2
HR - Croazia 2
LB - Libano 2
PA - Panama 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
GE - Georgia 1
IM - Isola di Man 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MD - Moldavia 1
MN - Mongolia 1
NO - Norvegia 1
OM - Oman 1
RO - Romania 1
RS - Serbia 1
SC - Seychelles 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
UY - Uruguay 1
Totale 10.967
Salva come PNG Salva come JPEG
Città #
Dallas 939
Singapore 870
Santa Clara 676
Moscow 516
Chandler 445
Dublin 327
Abidjan 291
Ashburn 261
Hefei 256
Chicago 229
San Jose 226
Catania 167
Boardman 138
Seoul 131
Los Angeles 124
Jacksonville 105
Beijing 98
Civitanova Marche 90
Cambridge 80
Lawrence 79
Andover 76
Dakar 62
Nanjing 60
Saint Petersburg 60
Toronto 52
São Paulo 49
Des Moines 48
New York 47
Council Bluffs 39
Buffalo 34
Ho Chi Minh City 33
Bremen 32
Milan 28
Hanoi 27
Dong Ket 26
Denver 24
Warsaw 24
Wilmington 24
Houston 22
Lauterbourg 22
Cotonou 21
San Francisco 20
Amsterdam 19
Johannesburg 18
Rome 18
Tokyo 18
Columbus 17
Nanchang 17
Orem 17
Shenyang 17
The Dalles 16
Chennai 15
Hong Kong 15
Montreal 15
Phoenix 15
Belo Horizonte 14
Lappeenranta 14
Palermo 14
Rio de Janeiro 14
Hebei 13
London 13
Poplar 13
Seattle 13
Brooklyn 12
Mascalucia 12
Munich 12
Mexico City 11
Naples 11
Ottawa 11
Redwood City 11
Stockholm 11
Bernareggio 10
Kiev 10
Manchester 10
San Mateo 10
Ankara 9
Mumbai 9
Atlanta 8
Boston 8
Brasília 8
Giarre 8
Porcari 8
Porto Alegre 8
Rende 8
Abu Dhabi 7
Florence 7
Helsinki 7
Istanbul 7
Pune 7
Redondo Beach 7
Sorocaba 7
Tianjin 7
Charlotte 6
Genoa 6
Goiânia 6
Guangzhou 6
Jinan 6
Padova 6
Salvador 6
St Louis 6
Totale 7.512
Salva come PNG Salva come JPEG
Nome #
The ocular ecosystem in the discoid lupus erythematosus 221
After the sweet comes the bitter. Time to halt the diabetic neuropathy epidemic 162
Cancer Risk and Multiple Sclerosis: Evidence From a Large Italian Cohort 156
Amyotrophic lateral sclerosis: differential diagnosis with cervical myeloradiculopathy 152
Aging eye microbiota in dry eye syndrome in patients treated with enterococcus faecium and saccharomyces boulardii 148
Efficacy and safety of extracranial vein angioplasty in multiple sclerosis: A randomized clinical trial 140
Effectiveness and safety of Rituximab in demyelinating diseases spectrum: An Italian experience 139
Different patterns of acute saccadic response to levodopa in de novo Parkinson’s disease 137
Functional stress and microbiota eye in subjects with type 2 diabetes: a multifactorial approach 137
An update on the safety of treating relapsing-remitting multiple sclerosis 135
Amniotic membrane use in type 2 diabetes patients with chronic ulcers: Microbiological evaluation and therapeutic benefits 128
Retinal Thickness and Microvascular Pattern in Early Parkinson's Disease 128
Cancer risk assessment in multiple sclerosis patients in the Eastern Sicily 126
Microbiological Etiology of Chronic skin lesions in type 2 Diabetic Subjects 123
Clinical bacteriological aspects of the Human Amniotic Membrane in the diabetic foot. A case report 121
Are oligoclonal bands associated to lower retinal layer thickness at the time of relapsing remitting multiple sclerosis diagnosis? Evidence from an exploratory study 120
Lack of association between Toxocara canis and multiple sclerosis: A population-based case-control study 119
An update on the pharmacological management of pain in patients with multiple sclerosis 119
Lateral switch to IFN beta-1a 44 mcg may be effective as escalation switch to fingolimod in selected persons with relapsing remitting multiple sclerosis: a real-world setting experience 117
CSF neurotoxic metals/metalloids levels in amyotrophic lateral sclerosis patients: comparison between bulbar and spinal onset 117
An update on idiopathic intracranial hypertension in adults: a look at pathophysiology, diagnostic approach and management 117
Functional Neurological disorders; those bizarre and painfull disconnections between brain and body 116
A multicenter, observational, prospective study of self- and parent-reported quality of life in adolescent multiple sclerosis patients self-administering interferon-β1a using RebiSmartâ ¢â the FUTURE study 115
Retinal Thickness in Essential Tremor and Early Parkinson Disease: Exploring Diagnostic Insights 112
Early Intensive Versus Escalation Approach: Ten‐Year Impact on Disability in Relapsing Multiple Sclerosis 111
Clinical-Instrumental patterns of neurodegeneration in Essential Tremor: A data-driven approach 110
Effects of Nintendo Wii Fit® balance exercise program on physical abilities and quality of life in Multiple Sclerosis patients 108
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study 107
Changes in Anti-JCV Antibody Status in a Large Population of Multiple Sclerosis Patients Treated with Natalizumab 107
A dynamic interpretation of κFLC index for the diagnosis of multiple sclerosis: a change of perspective 106
Real-World Effectiveness of Cladribine for Patients with Multiple Sclerosis: A Sicilian Multicentric Experience (Rewind Study) 105
Early-Onset Alcohol Dependence and Multiple Sclerosis: Diagnostic Challenges 103
Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis Patients: Monocentric Case Series and Systematic Review of the Literature 102
A real-world evidence study of nabiximols in multiple sclerosis patients with resistant spasticity: Analysis in relation to the newly described 'spasticity-plus syndrome' 102
Migraine causes retinal and choroidal structural changes: evaluation with ocular coherence tomography 102
Inpatient versus outpatient rehabilitation for multiple sclerosis patients: effects on disability and quality of life 102
Cilostazol reduces dry eye symptoms and improve walking distance in patients with peripheral artery disease 101
Administration of subcutaneous interferon beta 1a in the evening: data from RELIEF study 101
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 101
Late-onset and young-onset relapsing-remitting multiple sclerosis: evidence from a retrospective long-term follow-up study 100
Pharmacoeconomics of synthetic therapies for multiple sclerosis 99
Prevalence and Incidence of Multiple Sclerosis in the City of Biancavilla 98
Etiology of chronic skin lesions in subjects with peripheral arterial disease 98
Subclinical involvement of eye movements detected by video-based eye tracking in myasthenia gravis 97
Changes in John Cunningham Virus Index in Multiple Sclerosis Patients Treated with Different Disease-Modifying Therapies 97
Gonadal Steroids and Sperm Quality in a Cohort of Relapsing Remitting Multiple Sclerosis: A Case-Control Study 97
A model-based study of internuclear ophthalmoparesis and ocular-motor fatigue in multiple sclerosis 96
Factors driving delayed time to multiple sclerosis diagnosis: Results from a population-based study 96
Esposizione ad elementi in tracce in aree ad alta incidenza di sclerosi multipla: un ruolo delle ceneri vulcaniche? 94
Retinal thickness and microvascular pathway in Idiopathic Rapid eye movement sleep behaviour disorder and Parkinson's disease 94
The Italian Multiple Sclerosis Register Experience With Cladribine 93
Palliative care in multiple sclerosis 93
Toxoplasma gondii and multiple sclerosis: a population-based case–control study 93
Immunological Subsets Characterization in Newly Diagnosed Relapsing–Remitting Multiple Sclerosis 93
Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing–remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study) 92
Active and non-active secondary progressive multiple sclerosis patients exhibit similar disability progression: results of an Italian MS registry study (ASPERA) 91
Abnormal Eye Movements due to Disease of the Extraocular Muscles and Their Innervation 90
Risk factors for ocular surface disorders in patients with type 2 diabetes 87
Aging with multiple sclerosis: prevalence and profile of cognitive impairment 86
Patients with multiple sclerosis choose a collaborative role in making treatment decision: results from the Italian multicenter SWITCH study 85
Valutazione dell’efficacia clinica-batteriologica dell’ofloxacina e della levofloxacina nelle congiuntiviti batteriche 85
Cardiovascular autonomic individual profile of relapsing-remitting multiple sclerosis patients and risk of extending cardiac monitoring after first dose fingolimod 85
Retinal Nerve Fiber Layer Thickness and Higher Relapse Frequency May Predict Poor Recovery after Optic Neuritis in MS Patients 84
Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY) 83
Multiple Sclerosis, COVID-19 and Vaccines: Making the Point 83
A post hoc evaluation of the shift in spasticity category in individuals with multiple sclerosis-related spasticity treated with nabiximols 83
First-year treatment response predicts the following 5-year disease course in patients with relapsing-remitting multiple sclerosis 83
A MACROSCALE MODELLING APPROACH FOR NONLINEAR ANALYSIS OF MASONRY ARCH BRIDGES 82
Microbiological characteristics of the ocular surface in the patients with discoid lupus erythematosus. 82
Multiple Sclerosis in the Mount Etna region: possible role of volcanogenic trace elements 81
Cerebrospinal fluid neurofilament light chains predicts early disease-activity in Multiple Sclerosis 81
Clinical and patient determinants of changing therapy in relapsing-remitting multiple sclerosis (SWITCH study) 80
Clinical effectiveness of different natalizumab interval dosing schedules in a large Italian population of patients with multiple sclerosis 80
eMSQOL-29: Prospective validation of the abbreviated, electronic version of MSQOL-54 79
The ocular surface in patients video display terminal (VDT) 79
The clinical value of Coop/Wonca charts in assessment of HRQoL in a large cohort of relapsing-remitting multiple sclerosis patients: Results of a multicenter study 78
Static postural control disturbances among the different multiple sclerosis phenotypes: A Neurocom Balance Manager®evaluation study 78
The effects of blood glucose regulation onn the microbiota ocular in Type II diabetic subjects 76
Natalizumab administration in multiple sclerosis patients during active SARS-CoV-2 infection: a case series 76
WII may improve physical abilities in multiple sclerosis: a randomized single blind study 74
Optic Nerve Head and Retinal Changes in Idiopathic Intracranial Hypertension: Correlation with Short-Term Cerebrospinal Fluid Pressure Monitoring 73
Pregnancy planning and management for women with multiple sclerosis: what has changed over the last 15 years? An Italian single-center experience 72
The efficacy of natalizumab and fingolimod on cognition in relapsing-remitting multiple sclerosis patients 72
Incidence of late onset multiple sclerosis in Italy: a population-based study 71
The mixture of bifidobacterium associated with fructooligosaccharides reduces the damage of the ocular surface 71
Pain Following the Use of Anesthesia Formulation Among Individuals Undergoing Cataract Surgery: A Randomized Controlled Trial 71
Microbiology synergism between tear substitutes and symbiotic treatment of patients with irritable bowel syndrome 70
Prevalence and incidence of cognitive impairment in multiple sclerosis: a population-based survey in Catania, Sicily 69
Effects of THC/CBD oromucosal spray on spasticity-related symptoms in people with multiple sclerosis: results from a retrospective multicenter study 69
Objective evaluation of Nintendo Wii Fit Plus balance program training on postural stability in Multiple Sclerosis patients: a pilot study 69
Pharmacokinetic drug evaluation of daclizumab for the treatment of relapsing-remitting multiple sclerosis 68
Evolution of the concept of vascular dementia 68
Long-term Cognitive Outcomes and Socioprofessional Attainment in People With Multiple Sclerosis With Childhood Onset 67
Early reduction of retinal thickness predicts physical and cognitive disability in newly diagnosed multiple sclerosis patients: results from a cross-sectional study 66
Treatment in worsening multiple sclerosis patients: new drugs are better than older ones? 66
Rituximab for the treatment of multiple sclerosis: a review 66
Lesion load may predict long-term cognitive dysfunction in multiple sclerosis patients 64
Pregnancy and the Postpartum Period in Women With Relapsing-Remitting Multiple Sclerosis Treated With Old and New Disease-Modifying Treatments: A Real-World Multicenter Experience 64
Functional stress and alteration of the ocular surface in subjects video display terminal (VDT) 63
Measurement Of Retinal Nerve Fibre Layer Thickness In Clinical Isolated Syndrome 63
Totale 9.716
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.024
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.024
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021151 0 0 0 0 0 0 28 8 21 19 34 41
2021/2022595 54 93 13 22 90 4 88 18 18 4 19 172
2022/20231.281 87 90 29 138 100 196 16 269 282 12 50 12
2023/2024708 34 155 41 32 27 159 11 56 8 12 109 64
2024/20252.725 61 376 137 148 499 399 120 60 222 270 219 214
2025/20264.964 393 590 983 438 984 1.273 303 0 0 0 0 0
Totale 11.189